Core Expertise

Where I Operate

Deep domain knowledge across three interconnected pillars of pharmaceutical market access and regulatory compliance.

MHRA PLPI Licensing & Compliance

Deep expertise in obtaining and managing MHRA Parallel Import Product Licences (PLPI), marketing authorisations, and post-approval compliance obligations within the UK's post-Brexit regulatory framework.

Learn more →

EU-GMP Supply Chain & GDP Distribution

End-to-end pharmaceutical supply chain management — from EU-GMP certified manufacturer qualification and audit through to GDP-compliant UK distribution and batch documentation traceability.

Learn more →

NHS Market Access & NICE HTA Strategy

Strategic market access expertise across high-value therapeutic categories — with a particular focus on oncology and hospital procurement — encompassing NICE HTA engagement and NHS formulary strategy.

Learn more →

Our Companies

The Group

Two complementary entities serving the UK and EU pharmaceutical ecosystem under MHRA oversight.

Active · UK Registered

NovaPharm Healthcare Ltd

UK-registered pharmaceutical wholesaler and market access specialist. Operating under MHRA oversight with GDP-compliant supply chain infrastructure serving NHS Trusts, independent pharmacies, and pharmaceutical wholesalers.

View company →
R&D & Services

NovaPharm InfoTech & Research

Pharmaceutical R&D and services subsidiary bridging Indian pharmaceutical manufacturing expertise with UK and EU regulatory compliance requirements. Covering MHRA, EMA, and Health Canada frameworks.

View company →

Publications & Essays

Written Work

In-depth analysis on pharmaceutical regulation, market access, and the business of building in regulated industries.

Regulatory Strategy

Regulated Industries: Building Where Others Won't

Analysis of MHRA-divergent pathways, post-Brexit product registration, and strategic distribution opportunities for international pharma companies entering the UK market.

Read article →
MHRA Compliance

What Parallel Import Actually Means

Comprehensive breakdown of the Parallel Import Product Licence application process, timelines, compliance obligations, and pharmacovigilance requirements under MHRA.

Read article →
Entrepreneurship

How to Win When the Odds Are Against You

Strategic framework for building in high-barrier regulated industries — covering resilience, market positioning, and the counterintuitive advantages of operating in complexity.

Read article →
View all publications →

Investment & Partnerships

Let's Build Together

I am open to strategic conversations with investors, co-founders, distributors, manufacturers, and institutional partners who want to operate at the intersection of pharmaceutical regulation and commercial scale.

Investor Relations

Equity and growth capital discussions for NovaPharm Healthcare Ltd's expansion into oncology and high-value NHS segments.

Distribution Partnerships

EU-based manufacturers seeking UK market entry via GDP-compliant parallel import routes and MHRA-licensed distribution channels.

Regulatory Collaboration

Pharma companies navigating post-Brexit UK registration, MHRA divergence, or Health Canada pathway alignment.

Strategic Advisory

Advisory roles and board-level engagements in pharmaceutical regulatory strategy, market access, and international expansion.

Start a conversation
Regulatory Framework
MHRA
Full UK licensing & pharmacovigilance compliance
Distribution Standard
GDP
EU Good Distribution Practice certified supply chain
Markets Served
UK · EU
Cross-border pharmaceutical access strategy
NHS Channels
Trusts · ICS
Hospital and formulary access for high-value therapies
Open to
Equity Investment Distribution Agreements Advisory Roles JV & Licensing Research Collaboration Media & Speaking

Contact

Connect

Connect to discuss pharmaceutical regulatory strategy, market access, partnership opportunities, or media enquiries.

Email LinkedIn Twitter / X All Profiles